Billionaire Profile
A
Global Rank
#554

Image: Lise-Marlène PUVILLAND auteure de la thèse licence d'utilisation CC BY-NC-ND 2.0 | CC BY-SA 4.0 | via Wikimedia Commons

Alain Merieux & family

CEO, Pharmaceuticals
FRANCE
Real-Time Net Worth
$7.015B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
-1.98% (24h)
Age
87
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
FRANCE

Biography

Alain Mérieux, born in Lyon, France, in 1938, is a prominent billionaire businessman renowned for his significant contributions to healthcare and public health. As the chairman of Institut Mérieux, he has dedicated his career to advancing diagnostics, immunotherapy, and nutrition. His grandfather, Marcel Mérieux, founded the institute in 1897. Alain founded bioMérieux in 1963, a company specializing in in vitro diagnostics. With a net worth of $7.3 billion as of 2024, he is a leading figure in the pharmaceutical industry and global health. Mérieux's career highlights include leadership roles in Institut Mérieux and bioMérieux, as well as political involvement in the Rhône-Alpes region.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Alain Mérieux was born on July 10, 1938, in Lyon, France. He hails from a distinguished lineage in the medical field. His father, Charles Mérieux, was a key figure in the pharmaceutical industry, and his grandfather, Marcel Mérieux, established Institut Mérieux in 1897. Alain pursued his education at the University of Lyon, earning a pharmacy degree, and enhanced his business acumen with a PMD from Harvard Business School.

Rise to Success

Mérieux's career is marked by his leadership within the family business. He founded bioMérieux in 1963, a company specializing in in vitro diagnostics. Under his leadership, bioMérieux developed diagnostic tests for infectious diseases, including tuberculosis. From 1968 to 1994, he served as Chairman and CEO of Institut Mérieux, focusing on human and veterinary vaccines. Mérieux also held the position of First Vice President of the Rhône-Alpes Regional Assembly from 1986 to 1998. He was awarded the China Reform Friendship Medal in 2018 for his contributions to China's reform and opening-up.

Key Business Strategies

Alain Mérieux has expanded the family's business through strategic initiatives, including the development of new bio-industrial activities and acquisitions. He has focused on partnerships, innovation, and international presence, contributing significantly to in vitro diagnostics, immunotherapy, and food safety.

Philanthropy

Alain Mérieux is the President of Fondation Mérieux, established by his father in 1967, and co-founded Fondation Christophe et Rodolphe Mérieux in 2001. These foundations are dedicated to combating infectious diseases in developing countries. The Mérieux family’s work has aimed to reach places where diagnostics are scarce.

Career Milestones

1963

Founded bioMérieux

Established the in vitro diagnostics company.

1968-1994

Chairman and CEO of Institut Mérieux

Led the world leader in human and animal vaccines.

1986-1998

First Vice President of the Rhône-Alpes Regional Assembly

Oversaw International Relations, Economic Development, Research and Higher Education.

2018

Awarded China Reform Friendship Medal

Recognized for contributions to China's reform and opening-up.

Philanthropy & Social Impact

Global Health

Fondation Mérieux

N/A

Fighting infectious diseases in developing countries.

Global Health

Fondation Christophe et Rodolphe Mérieux

N/A

Dedicated to combating infectious diseases in developing countries.